Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1241 Views
eMediNexus 03 June 2018
The US Food and Drug Administration (FDA) has approved a combination of amlodipine besylate and the nonsteroidal anti-inflammatory drug (NSAID) celecoxib (Consensi, Kitov Pharma) for individuals with osteoarthritis pain and hypertension.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.
